Condition: Focal Hand Dystonia · Sponsor: Alain Kaelin
This study is a multicenter, double-blind, randomized placebo controlled, parallel group, superiority trial in order to test the superiority of intramuscular injections of IncobotulinumtoxinA against placebo using a 1:1 allocation ratio.
This description comes directly from the study's public registry record.
Alain Kaelin, Prof. · +41 (0)91 811 62 57 · alain.kaelin@eoc.ch
Always discuss trial participation with your own doctor first.
| Inselspital - University Hospital Berne | Bern, Switzerland | Not Yet Recruiting |
| Centre hospitalier universitaire vaudois (CHUV) | Lausanne, Switzerland | Not Yet Recruiting |
| Neurocentro della Svizzera Italiana | Lugano, Switzerland | Recruiting |
| Neurocenter of St. Gallen | Sankt Gallen, Switzerland | Not Yet Recruiting |
| USZ- Univerity Hospital Zurich | Zurich, Switzerland | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03977493